跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GALVUS 50 mg COMPRIMIDOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
GALVUS 50 mg COMPRIMIDOS
Approved
STANDARD
GALVUS 50 mg COMPRIMIDOS
Novartis Europharm Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 15, 2021
Approval ID
bf1f6ac19ad59fbb
Company
Novartis Europharm Limited
Type
Standard
Approval Details
Approval Id
bf1f6ac19ad59fbb
Drug Cima Aemps Name
GALVUS 50 mg COMPRIMIDOS
Register Number
07414005IP
Holder Company Name
Novartis Europharm Limited
Marketing Company Name
Difarmed S.L.
Holder Company Detail Path
/organization/novartis-europharm-limited
Authorization Date
2021-02-15
Dosage Form
COMPRIMIDO
Dose
50mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Novartis Europharm Limited
Company Detail Path
/organization/novartis-europharm-limited
Company Information
Pharmaceutical Company Name
NOVARTIS EUROPHARM LIMITED
Country Name
United Kingdom
City Name
camberley,country_gb
Address
200 Frimley Business Park
Active Ingredients
VILDAGLIPTINA
50 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 15, 2021
Approval ID
bf1f6ac19ad59fbb
Type
Standard
Back to CIMA-AEMPS Approvals